Clinical trials: Seronegative Arthritis
SpA, PsA
Closing the Gap in Care in Seronegative Inflammatory Arthritis
Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care.
- Trial name
- Metrix II (NCT01749618)
- Testing
- Education and Feedback
- Where
- 9 sites in Canada
- Volunteers
- 40 people
- Sponsor
- Pope Research Corporation